AX-2025-020269 · MGF · GGPeps lot GGPE-2506-T1988

Section 1

Results

Measured against the index acceptance specification for the growth-hormone axis peptides class. A specification is a decision the index made; a result is a measurement. See where each threshold came from.

Parameter	Method	Result	Unit	Index spec
Purity	RP-HPLC, 25 min gradient, 214 nm	98.70	% area	≥ 97.5	PASS
Total impurities	RP-HPLC, sum of reported peaks	1.30	% area	≤ 2.5	PASS
Largest single impurity	RP-HPLC — deamidated (+1 Da)	0.55	% area	≤ 1.00	PASS
Identity — theoretical monoisotopic mass	calculated from molecular formula	2886.5117	Da	—	NOT TESTED
Identity — observed monoisotopic mass	LC-MS, unit resolution (single quadrupole)	2886.5628	Da	—	NOT TESTED
Mass accuracy	observed vs theoretical	+17.7	ppm	± 15	FAIL
Total peptide content	by difference from the gravimetric mass balance	89.56	%w/w	—	NOT TESTED
Target-compound content	total peptide content × purity	88.40	%w/w	—	NOT TESTED
Gross fill (as weighed)	five-place balance, under nitrogen	2.18	mg	2 mg declared	NOT TESTED
Recovered target peptide	gross fill × target content	1.927	mg	2 mg claim	NOT TESTED
Recovery against label claim	recovered ÷ claim	96.4	%	90.0 – 110.0	PASS
Water content	Karl Fischer, coulometric, duplicate	4.20	%	≤ 9.0	PASS
Counter-ion (acetate)	anion-exchange ion chromatography	5.50	%	≤ 12.0	PASS
Residual solvent + inorganic residue	estimated — see /methods/residual-solvents-q3c/	0.74	%	—	NOT TESTED
Endotoxin	not ordered on this submission	not determined	—	≤ 5.0	NOT TESTED
Sterility	not ordered on this submission	not determined	—	no growth	NOT TESTED
Appearance	visual, diffuse light, black and white background	White cake, partial shrinkage from vial wall	—	white to off-white intact cake	FAIL
Reconstitution clarity	reconstituted per submitter procedure	Clear, colourless, no visible particulates	—	clear, no visible particulates	PASS
pH (reconstituted, 1 mg/mL)	potentiometric, two-point calibration	5.08	—	2.5 – 8.0	PASS
Retention time (observed)	RP-HPLC, 25 min gradient	9.86	min	9.84 ± 0.30 (normalised)	PASS
Peak asymmetry (10 % height)	Ph. Eur. 2.2.46	1.23	—	0.80 – 1.50	PASS
Plate count, main peak	N = 5.54 (t/w½)²	54,384	—	≥ 20,000	PASS
Resolution to nearest impurity	vs deamidated (+1 Da)	1.15	—	no index criterion	REPORTED

Section 2

Chromatogram and peak integration

The figure is drawn from the table. It is not an independent illustration — if a number in the table changed, the trace would change with it.

Figure 1. RP-HPLC trace, 25 min gradient, 214 nm. Drawn from the peak-integration table below: peak positions are the reported retention times, peak areas are the reported area percentages, peak widths follow the reported plate count of 54,384, and skew follows the reported asymmetry factor of 1.23. Baseline noise is seeded from the report ID and is illustrative. The lower panel is the same trace at a stated vertical expansion with the slow gradient drift subtracted, because at full scale a 0.55 % impurity against a 98.70 % main peak is a line two pixels tall; the main peak runs off-scale there by design.

#	Peak	RT	Area (µV·s)	% area	Δ mass (Da)
1	MGF — main peak	9.86	4,797,126	98.70	—
2	deamidated (+1 Da)	9.66	26,732	0.55	+0.984
3	truncated (1-20)	8.84	19,441	0.40	-486.271
4	aspartimide (−18 Da)	10.13	10,207	0.21	-18.011
5	acetyl adduct (+42 Da)	10.19	6,804	0.14	+42.011
Closure check — purity + Σ impurities				100.00	CLOSES

Reporting threshold 0.05 % area. Peaks below it are not reported and are therefore excluded from the total, which overstates purity by their sum — see peak integration.

Section 3

Mass spectrum and identity

Theoretical monoisotopic mass 2886.5117 Da, computed from C121H200N42O37. All ppm figures on this site are against monoisotopic values — see why that matters.

Figure 2. ESI charge-state envelope, unit-resolution instrument. Sticks are placed at m/z = (M + z × 1.007276)/z for the observed neutral mass of 2886.5628 Da. Sodium (+21.982/z) and potassium (+37.956/z) adducts are shown where the parent charge state exceeds 25 % relative abundance; they are adducts of the same molecule and are not impurities.

Charge	Theoretical m/z	Observed m/z	Δ m/z	Rel. abundance (%)
5+	578.3096	578.3198	0.0102	8.2
4+	722.6352	722.6480	0.0128	57.4
3+	963.1778	963.1949	0.0171	100.0
2+	1444.2631	1444.2887	0.0256	52.9

Section 4

Gravimetric mass balance

Water, counter-ion, residual and total peptide content are exhaustive and mutually exclusive categories. They must account for 100 % of the cake mass. The index closes this to within 0.02 pp and the build asserts it.

Component	Determination	%w/w of cake
Water	Karl Fischer	4.20
Counter-ion (acetate)	ion chromatography	5.50
Residual solvent + inorganic residue	estimated	0.74
Total peptide content	by difference	89.56
Total		100.00 CLOSES

Supplier certificate, as declared

The supplier's own figures for this lot, beside the independent measurement. Divergence is assessed against the batch median, not against this single report — see rule AX-R05.

Figure	Supplier COA	This report	Index note
Purity (% area)	98.29	98.70	divergence -0.20 pp vs batch median
Total impurities (% area)	1.71	1.30
Largest single impurity (% area)	0.92	0.55
Water (%)	3.6	4.20
Counter-ion (%)	not stated	5.50
Peptide content (%w/w)	91.6	89.56
Endotoxin (EU/mg)	not stated	not determined
Method stated on certificate	YES	—	column, gradient and wavelength given

Section 5

Provenance and caveats

Where a sample came from changes the weight of the evidence. The index treats it as a first-class field.

Sample provenance: Supplier-supplied
Evidentiary weight: Weaker evidence. Read with the caveat below.
Chain of custody: Supplier despatch → laboratory direct (courier, cold pack, 5 d) → assay. Submitter did not handle the vial.
Assay date: 12 Oct 2025
Submitted to the index: 14 Oct 2025
Laboratory: Medutest, Ljubljana, Slovenia
Method basis: 25 min gradient · unit-resolution MS
Verification status: IDENTITY CONSISTENT

What this report does not establish

That the compound is not a near-isobaric alternative. Identity was confirmed at unit mass resolution, which cannot exclude species differing by 1 or 2 Da. The specific alternatives not excluded are named in the identity block above.
That the material is free of bacterial endotoxin. Endotoxin was not measured. No chromatographic result bears on it.
That the material is sterile. Sterility was not tested.
That any other vial in the same lot has the same composition. One vial was tested. Within-lot vial-to-vial variation in this index has a median of 0.28 pp and a 90th percentile of 0.74 pp.
That any other lot from the same supplier has the same composition. Batch-to-batch variation is larger than within-batch variation for every supplier here.
That the material is suitable for administration to a human or an animal. These are research compounds. No result on this site is a safety assessment and the index takes no position on use.
That the material was manufactured by the supplier that sold it. Contract synthesis is normal in this market and twenty-nine batches in the index fingerprint to a bulk from a different company than the one named on the label.

Section 6

Annotations 4

Signed technical comments from index contributors. Not a discussion forum — annotations question or contextualise the result, and the data team replies where a reply is warranted.

isotope_cluster14 Oct 2025

At this mass the monoisotopic peak may not be the most intense peak in the cluster. Picking the apex instead of the monoisotopic peak produces a systematic positive error of roughly the size flagged here.

sodium_adduct14 Oct 2025

Deconvolution software defaults differ on whether to report the monoisotopic or the most abundant isotopologue. The setting is rarely stated and it accounts for a substantial share of the flags on this rule.

fill_homogeneity14 Oct 2025

Three vials from one lot sent to three laboratories blind is the design that removes this ambiguity. It costs three tests and it settles the question permanently for that lot.

buyer_sourced14 Oct 2025

Blind purchase through an ordinary retail channel is the provenance class this index weights. Nothing prevents anyone from generating one for GGPE-2506-T1988; it costs the price of a vial.

Section 7

Related records

Same batch — lot GGPE-2506-T1988 n=4

Report	Lot	Lab	Quarter	Purity %	Water %	Recovery %	Provenance	Flags	Result
AX-2025-020268	GGPE-2506-T1988	PeptideMeter	2025-Q4	98.02	4.30	101.5	Buyer-sourced	0	PASS
AX-2025-020270	GGPE-2506-T1988	VendorInvestigate	2025-Q4	98.57	4.34	88.6	Buyer-sourced	1	MARGINAL
AX-2025-020271	GGPE-2506-T1988	Nordanalyt	2025-Q4	98.40	4.76	—	Buyer-sourced	0	PASS

Batch rollup and reproducibility assessment →

Cross-sections

Other recent MGF records in the index.
Report	Supplier	Lot	Lab	Quarter	Purity %	Water %	Recovery %	Provenance	Result
AX-2026-043660	PPG	PPG-2512-G7713	Janoshik	2026-Q2	99.30	4.25	95.8	Buyer-sourced	PASS
AX-2026-043656	PPG	PPG-2512-G7713	PeptideMeter	2026-Q2	99.09	4.22	99.3	Buyer-sourced	PASS
AX-2026-043657	PPG	PPG-2512-G7713	Janoshik	2026-Q2	99.06	4.25	107.0	Buyer-sourced	PASS
AX-2026-043466	BCH	BCH-2511-D5168	Janoshik	2026-Q2	99.04	5.33	103.5	Buyer-sourced	PASS
AX-2026-043464	BCH	BCH-2511-D5168	VendorInvestigate	2026-Q2	99.39	5.79	100.2	Buyer-sourced	PASS
AX-2026-043655	PPG	PPG-2512-G7713	Medutest	2026-Q2	99.03	4.14	99.6	Buyer-sourced	PASS
AX-2026-043467	BCH	BCH-2511-D5168	Janoshik	2026-Q2	99.46	5.95	—	Supplier-supplied	PASS
AX-2026-043652	PPG	PPG-2512-G7713	Janoshik	2026-Q2	99.33	3.87	101.6	Buyer-sourced	PASS

Other recent GGPeps records in the index.
Report	Compound	Lot	Lab	Quarter	Purity %	Water %	Recovery %	Provenance	Result
AX-2026-042784	CJC-1295 (no DAC)	GGPE-2606-E1234	Medutest	2026-Q3	98.27	4.55	—	Buyer-sourced	PASS
AX-2026-042786	CJC-1295 (no DAC)	GGPE-2606-E1234	Janoshik	2026-Q3	98.22	3.77	—	Buyer-sourced	PASS
AX-2026-042858	Selank	GGPE-2603-J2447	VendorInvestigate	2026-Q3	98.87	8.85	99.4	Buyer-sourced	FAIL
AX-2026-042783	CJC-1295 (no DAC)	GGPE-2606-E1234	Janoshik	2026-Q3	98.22	4.45	90.6	Buyer-sourced	PASS
AX-2026-042757	Melanotan II	GGPE-2603-P1474	Janoshik	2026-Q3	99.54	6.78	92.0	Buyer-sourced	PASS
AX-2026-042785	CJC-1295 (no DAC)	GGPE-2606-E1234	PeptideMeter	2026-Q3	97.70	4.64	91.4	Buyer-sourced	FAIL
AX-2026-042756	Melanotan II	GGPE-2603-P1474	Nordanalyt	2026-Q3	99.17	7.04	—	Buyer-sourced	PASS
AX-2026-042755	Melanotan II	GGPE-2603-P1474	Nordanalyt	2026-Q3	99.25	6.58	90.4	Buyer-sourced	PASS